BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18606697)

  • 1. Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils.
    Southgate EL; He RL; Gao JL; Murphy PM; Nanamori M; Ye RD
    J Immunol; 2008 Jul; 181(2):1429-37. PubMed ID: 18606697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of three mouse formyl peptide receptors.
    He HQ; Liao D; Wang ZG; Wang ZL; Zhou HC; Wang MW; Ye RD
    Mol Pharmacol; 2013 Feb; 83(2):389-98. PubMed ID: 23160941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
    Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
    He R; Tan L; Browning DD; Wang JM; Ye RD
    J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
    Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
    J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
    Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A
    Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
    Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
    J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formyl-peptide receptor 2 governs leukocyte influx in local
    Weiss E; Hanzelmann D; Fehlhaber B; Klos A; von Loewenich FD; Liese J; Peschel A; Kretschmer D
    FASEB J; 2018 Jan; 32(1):26-36. PubMed ID: 28855276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.
    Riesselman M; Miettinen HM; Gripentrog JM; Lord CI; Mumey B; Dratz EA; Stie J; Taylor RM; Jesaitis AJ
    J Immunol; 2007 Aug; 179(4):2520-31. PubMed ID: 17675514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions.
    Woloszynek JC; Hu Y; Pham CT
    J Biol Chem; 2012 Oct; 287(41):34101-9. PubMed ID: 22879591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.
    Sogawa Y; Ohyama T; Maeda H; Hirahara K
    Immunology; 2011 Mar; 132(3):441-50. PubMed ID: 21039475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes.
    Liu M; Chen K; Yoshimura T; Liu Y; Gong W; Wang A; Gao JL; Murphy PM; Wang JM
    Sci Rep; 2012; 2():786. PubMed ID: 23139859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus.
    Dürr MC; Kristian SA; Otto M; Matteoli G; Margolis PS; Trias J; van Kessel KP; van Strijp JA; Bohn E; Landmann R; Peschel A
    Cell Microbiol; 2006 Feb; 8(2):207-17. PubMed ID: 16441432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Becker EL
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA/ROCK downregulates FPR2-mediated NADPH oxidase activation in mouse bone marrow granulocytes.
    Filina JV; Gabdoulkhakova AG; Safronova VG
    Cell Signal; 2014 Oct; 26(10):2138-46. PubMed ID: 24880063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.
    Lavigne MC; Murphy PM; Leto TL; Gao JL
    Cell Immunol; 2002; 218(1-2):7-12. PubMed ID: 12470609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenylalanine, to the receptors on rabbit neutrophils.
    Kermode JC; Muthukumaraswamy N; Freer RJ
    J Leukoc Biol; 1988 May; 43(5):420-8. PubMed ID: 2836540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
    Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
    J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.